Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roivant Sciences Ltd.

19.87
+0.27001.38%
Volume:11.64M
Turnover:229.24M
Market Cap:13.57B
PE:-28.71
High:19.89
Open:19.33
Low:19.32
Close:19.60
52wk High:20.09
52wk Low:8.73
Shares:683.00M
Float Shares:414.56M
Volume Ratio:1.32
T/O Rate:2.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6921
EPS(LYR):-0.2371
ROE:-18.15%
ROA:-12.59%
PB:3.12
PE(LYR):-83.81

Loading ...

Vor Bio Appoints Jeremy Sokolove as Chief Medical Officer

Reuters
·
Nov 03

BRIEF-Roivant To Report Financial Results For The Second Quarter Ended September 30, 2025, And Provide Business Update On Monday, November 10, 2025

Reuters
·
Oct 28

Roivant Sciences Ltd. to Release Second Quarter Financial Results

Reuters
·
Oct 28

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

THOMSON REUTERS
·
Oct 28

Roivant Sciences (ROIV): Assessing Valuation After Positive Phase 3 Results for Brepocitinib

Simply Wall St.
·
Oct 25

Roivant Sciences on Track for Longest Winning Streak Since July 2023 -- Data Talk

Dow Jones
·
Oct 24

Roivant Sciences President & Immunovant CEO Eric Venker Reports Disposal of Common Shares

Reuters
·
Oct 15

BRIEF-Roivant Sciences Files For Mixed Shelf Offering - SEC Filing

Reuters
·
Oct 04

Roivant Sciences Ltd Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Oct 04

Roivant Sciences files automatic mixed securities shelf

TIPRANKS
·
Oct 04

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Climb Bio (CLYM) and Crinetics Pharmaceuticals (CRNX)

TIPRANKS
·
Oct 01

Goldman Sachs Sticks to Their Buy Rating for Roivant Sciences (ROIV)

TIPRANKS
·
Sep 30

Eric Venker, President & Immunovant CEO, Reports Disposal of Common Shares in Roivant Sciences Ltd

Reuters
·
Sep 24

Ramaswamy Sells $23 Million of Roivant Sciences Stock -- Barron's

Dow Jones
·
Sep 20

Roivant Sciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 18

Roivant Sciences price target raised to $20 from $18 at H.C. Wainwright

TIPRANKS
·
Sep 18

Roivant Sciences Ltd : Jefferies Raises Target Price to $20 From $18

THOMSON REUTERS
·
Sep 18

Roivant Sciences Ltd : JP Morgan Raises Target Price to $20 From $16

THOMSON REUTERS
·
Sep 18

Goldman Sachs Remains a Buy on Roivant Sciences (ROIV)

TIPRANKS
·
Sep 18

Bank of America Securities Sticks to Its Hold Rating for Roivant Sciences (ROIV)

TIPRANKS
·
Sep 18